P
PEN
PENUnverified2 segments tracked|2 years of data|Annual (10-K)
Total Revenue
$1.2B12.9%
FY2024
Operating Segments
2Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Thrombectomy
Segment Shift
Thrombectomy has grown from 64.0% to 68.3% of total revenue since FY2023, with 0.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Thrombectomy | $815M | $0 | 0.0% | 68.3% | +20.4% |
| Embolization | $379M | $0 | 0.0% | 31.7% | -0.5% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free